Brief: CytoTools Introduces New Strategic Investor

bioXXmed AG

26/08/2020 08:53

Aug 26 (Reuters) - CYTOTOOLS AG  T5OG.DE :
    * CYTOTOOLS INTRODUCES NEW STRATEGIC INVESTOR AND
RESTRUCTURES
CAPITAL MARKET COMMUNICATION
    * PHARMA-CDMO KLOCKE GROUP PARTICIPATES AS NEW STRATEGIC
INVESTOR
    * PROCEEDS FROM CAPITAL INCREASE IN AMOUNT OF APPROXIMATELY
EUR
3.7 MILLION WILL PRIMARILY BE MADE AVAILABLE TO HOLDING COMPANY
DERMATOOLS TO FINANCE PHASE III OF APPROVAL PROCESS FOR ACTIVE
INGREDIENT DPOCL IN EUROPE
    * MILESTONE FOR FINANCING OF PHASE III OF APPROVAL PROCESS
FOR
DERMAPRO(R)

Source text for Eikon:  ID:nEQ3WljBza 
Further company coverage:  T5OG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))